Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Time course, clinical pathways, and long‐term hazards risk trends of disease progression in patients with classic mycosis fungoides
Pietro Quaglino, Nicola Pimpinelli, Emilio Berti, et al.
Cancer (2012) Vol. 118, Iss. 23, pp. 5830-5839
Open Access | Times Cited: 116

Showing 1-25 of 116 citing articles:

Cutaneous Lymphoma International Consortium Study of Outcome in Advanced Stages of Mycosis Fungoides and Sézary Syndrome: Effect of Specific Prognostic Markers on Survival and Development of a Prognostic Model
Julia Scarisbrick, H. Miles Prince, Maarten H. Vermeer, et al.
Journal of Clinical Oncology (2015) Vol. 33, Iss. 32, pp. 3766-3773
Open Access | Times Cited: 364
Phase 1/2 study of mogamulizumab, a defucosylated anti-CCR4 antibody, in previously treated patients with cutaneous T-cell lymphoma
Madeleine Duvic, Lauren Pinter‐Brown, Francine M. Foss, et al.
Blood (2015) Vol. 125, Iss. 12, pp. 1883-1889
Open Access | Times Cited: 215
Clinical Staging and Prognostic Factors in Folliculotropic Mycosis Fungoides
Suzanne van Santen, R.E.J. Roach, Remco van Doorn, et al.
JAMA Dermatology (2016) Vol. 152, Iss. 9, pp. 992-992
Open Access | Times Cited: 148
Prognostic factors, prognostic indices and staging in mycosis fungoides and Sézary syndrome: where are we now?
Julia Scarisbrick, Y.H. Kim, Sean Whittaker, et al.
British Journal of Dermatology (2014) Vol. 170, Iss. 6, pp. 1226-1236
Closed Access | Times Cited: 138
Blood classification and blood response criteria in mycosis fungoides and Sézary syndrome using flow cytometry: recommendations from the EORTC cutaneous lymphoma task force
Julia Scarisbrick, Emmilia Hodak, M. Bagot, et al.
European Journal of Cancer (2018) Vol. 93, pp. 47-56
Open Access | Times Cited: 133
Global patterns of care in advanced stage mycosis fungoides/Sezary syndrome: a multicenter retrospective follow-up study from the Cutaneous Lymphoma International Consortium
Pietro Quaglino, Milena Maule, H. Miles Prince, et al.
Annals of Oncology (2017) Vol. 28, Iss. 10, pp. 2517-2525
Open Access | Times Cited: 122
New insights into folliculotropic mycosis fungoides (FMF): A single-center experience
Emmilia Hodak, Iris Amitay‐Laish, Lihi Atzmony, et al.
Journal of the American Academy of Dermatology (2016) Vol. 75, Iss. 2, pp. 347-355
Closed Access | Times Cited: 113
Mycosis fungoides and Sézary syndrome: clinical presentation, diagnosis, staging, and therapeutic management
Denis Miyashiro, José Antônio Sanches
Frontiers in Oncology (2023) Vol. 13
Open Access | Times Cited: 24
Treatment of early‐stage mycosis fungoides: results from the PROspective Cutaneous Lymphoma International Prognostic Index (PROCLIPI) study*
Pietro Quaglino, H. Miles Prince, Richard Cowan, et al.
British Journal of Dermatology (2020) Vol. 184, Iss. 4, pp. 722-730
Open Access | Times Cited: 61
Advanced-stage mycosis fungoides: role of the signal transducer and activator of transcription 3, nuclear factor-κB and nuclear factor of activated T cells pathways
Cristina Pérez, R. Mondéjar, Nuria García‐Díaz, et al.
British Journal of Dermatology (2019) Vol. 182, Iss. 1, pp. 147-155
Open Access | Times Cited: 43
Molecular pathogenesis of Cutaneous T cell Lymphoma: Role of chemokines, cytokines, and dysregulated signaling pathways
Kalyani Patil, Shilpa Kuttikrishnan, Abdul Quaiyoom Khan, et al.
Seminars in Cancer Biology (2021) Vol. 86, pp. 382-399
Open Access | Times Cited: 40
Mycosis Fungoides and Sézary Syndrome: An Integrative Review of the Pathophysiology, Molecular Drivers, and Targeted Therapy
Nuria García‐Díaz, Miguel Á. Piris, Pablo L. Ortiz‐Romero, et al.
Cancers (2021) Vol. 13, Iss. 8, pp. 1931-1931
Open Access | Times Cited: 37
Flow cytometry for the assessment of blood tumour burden in cutaneous T‐cell lymphoma: towards a standardized approach
Maarten H. Vermeer, Hélène Moins‐Teisserenc, M. Bagot, et al.
British Journal of Dermatology (2022) Vol. 187, Iss. 1, pp. 21-28
Open Access | Times Cited: 23
Insights into treatment of patients with mycosis fungoides or Sézary syndrome using mogamulizumab
Francine M. Foss, Youn H. Kim, Julia Scarisbrick, et al.
Journal of Dermatological Treatment (2025) Vol. 36, Iss. 1
Open Access
Overall and Cause‐Specific Mortality Among Patients With Cutaneous T‐Cell Lymphoma in the United States
Lauren Shea, Mayur Narkhede, Karthik Chamarti, et al.
eJHaem (2025) Vol. 6, Iss. 2
Open Access
Phenotypical Markers, Molecular Mutations, and Immune Microenvironment as Targets for New Treatments in Patients with Mycosis Fungoides and/or Sézary Syndrome
Pietro Quaglino, Paolo Fava, Alessandro Pileri, et al.
Journal of Investigative Dermatology (2020) Vol. 141, Iss. 3, pp. 484-495
Open Access | Times Cited: 34
Diagnosis of Early Mycosis Fungoides
Tomomitsu Miyagaki
Diagnostics (2021) Vol. 11, Iss. 9, pp. 1721-1721
Open Access | Times Cited: 31
Extracorporeal photopheresis for the treatment of erythrodermic cutaneous T‐cell lymphoma: a single center clinical experience with long‐term follow‐up data and a brief overview of the literature
Pietro Quaglino, Robert Knobler, Maria Teresa Fierro, et al.
International Journal of Dermatology (2013) Vol. 52, Iss. 11, pp. 1308-1318
Closed Access | Times Cited: 41
Advanced-Stage Mycosis Fungoides and Sézary Syndrome: Survival and Response to Treatment
Silvia Alberti Violetti, Rakhshandra Talpur, Megan J. Schlichte, et al.
Clinical Lymphoma Myeloma & Leukemia (2015) Vol. 15, Iss. 6, pp. e105-e112
Closed Access | Times Cited: 39
Second Primary Malignancies in CTCL Patients from 1992 to 2011: A SEER-Based, Population-Based Study Evaluating Time from CTCL Diagnosis, Age, Sex, Stage, and CD30+ Subtype
Kyle T. Amber, Romi Bloom, Keyvan Nouri
American Journal of Clinical Dermatology (2015) Vol. 17, Iss. 1, pp. 71-77
Closed Access | Times Cited: 38
Doxycycline is an NF-κB inhibitor that induces apoptotic cell death in malignant T-cells
Carolina V. Alexander‐Savino, Matthew S. Hayden, Christopher T. Richardson, et al.
Oncotarget (2016) Vol. 7, Iss. 46, pp. 75954-75967
Open Access | Times Cited: 36
Dermoscopy of Lymphomas and Pseudolymphomas
Caterina Bombonato, Riccardo Pampena, Aimilios Lallas, et al.
Dermatologic Clinics (2018) Vol. 36, Iss. 4, pp. 377-388
Closed Access | Times Cited: 32
Spiky follicular mycosis fungoides: a clinicopathologic study of 8 cases
Carlo Tomasini, Werner Kempf, Mauro Novelli, et al.
Journal of Cutaneous Pathology (2014) Vol. 42, Iss. 3, pp. 164-172
Open Access | Times Cited: 33
Delay in the Histopathologic Diagnosis of Mycosis Fungoides
Anne Guldhammer Skov, Robert Gniadecki
Acta Dermato Venereologica (2015) Vol. 95, Iss. 4, pp. 472-475
Open Access | Times Cited: 30
Prognostic indicators for mycosis fungoides in a Greek population
Vasiliki Nikolaou, Evangelia Papadavid, Aikaterini Patsatsi, et al.
British Journal of Dermatology (2016) Vol. 176, Iss. 5, pp. 1321-1330
Closed Access | Times Cited: 30
Page 1 - Next Page

Scroll to top